Evidence map›Paper›PMID 38956396›Full record

ArticleCell death & disease2024

Correction: Pivotal role of IL-8 derived from the interaction between osteosarcoma and tumor-associated macrophages in osteosarcoma growth and metastasis via the FAK pathway.

Rikito Tatsuno, Jiro Ichikawa, Yoshihiro Komohara, Cheng Pan, Tomonori Kawasaki, Atsushi Enomoto, Kaoru Aoki, Keiko Hayakawa, Shintaro Iwata, Takahiro Jubashi and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Hyperprogressive disease in carcinoma induced by immune checkpoint inhibitor therapy: a systematic review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Rikito TatsunoDepartment of Orthopaedic Surgery, University of Yamanashi, Yamanashi, Japan.
Jiro IchikawaDepartment of Orthopaedic Surgery, University of Yamanashi, Yamanashi, Japan. jichi@sb4.so-net.ne.jp.ORCID http://orcid.org/0000-0002-9850-6047
Yoshihiro KomoharaDepartment of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Cheng PanDepartment of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Tomonori KawasakiDepartment of Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
Atsushi EnomotoDepartment of Pathology, Nagoya University Graduate School of Medicine, Aichi, Japan.ORCID http://orcid.org/0000-0002-9206-6116
Kaoru AokiPhysical Therapy Division, School of Health Sciences, Shinshu University, Nagano, Japan.
Keiko HayakawaDepartment of Orthopaedic Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Shintaro IwataDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
Takahiro JubashiDepartment of Orthopaedic Surgery, University of Yamanashi, Yamanashi, Japan.
Hirotaka HaroDepartment of Orthopaedic Surgery, University of Yamanashi, Yamanashi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38956396
PMCPMC11219726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.